Antinuclear autoantibodies (ANA) are commonly investigated, whereas their interpretation can be challenging, especially when the test is triggered by an unusual clinical presentation. Their detection is often incidental, the difficulty being the finding of a 'positive' result. This article sought to examine the role of ANA tests in clinical practice, along with their significance based on the patient context.
Key words
Antinuclear antibodies, connective tissue diseases